-
1
-
-
0004118752
-
Regulating Medicines in Europe: Competition
-
Routledge, London & New York
-
Abraham J. & G. Lewis (2001). Regulating Medicines in Europe: Competition, Expertise and Public Health. Routledge, London & New York.
-
(2001)
Expertise and Public Health
-
-
Abraham, J.1
Lewis, G.2
-
2
-
-
0031741756
-
Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine
-
American Academy of Pediatrics
-
American Academy of Pediatrics (1998). Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics, 102, 1483-1491.
-
(1998)
Pediatrics
, vol.102
, pp. 1483-1491
-
-
-
3
-
-
33644977262
-
Is technology integration the solution to biotechnology's low research and development productivity?
-
Amir-Aslani A. & S. Negassi (2006). Is technology integration the solution to biotechnology's low research and development productivity? Technovation, 26, 573-582.
-
(2006)
Technovation
, vol.26
, pp. 573-582
-
-
Amir-Aslani, A.1
Negassi, S.2
-
4
-
-
14044266006
-
Failure Rates in Drug Discovery and Development - Will We Ever Get Any Better?
-
Bains W. (2004). Failure Rates in Drug Discovery and Development - Will We Ever Get Any Better? Drug Discovery World, Vol 5; Part 4, pages 9-19
-
(2004)
Drug Discovery World
, vol.5
, Issue.4
, pp. 9-19
-
-
Bains, W.1
-
5
-
-
0142073829
-
Cancer patients sue for access to experimental drugs
-
Basu P. (2003). Cancer patients sue for access to experimental drugs. Nature Med vol 9, 10, p1231
-
(2003)
Nature Med
, vol.9
, Issue.10
-
-
Basu, P.1
-
6
-
-
19744380776
-
Approve trial investigators: Cardiovascular events associated with rofecoxib in a 3-year randomized colorectal adenoma chemoprevention trial
-
Bresalier R. S., Sandler R. S., & H. Quan (2005). Approve trial investigators: Cardiovascular events associated with rofecoxib in a 3-year randomized colorectal adenoma chemoprevention trial. N Engl J Med 352 (11): 1092-1102.
-
(2005)
N Engl J Med
, vol.352
, Issue.11
, pp. 1092-1102
-
-
Bresalier R., S.1
Sandler R., S.2
Quan, H.3
-
7
-
-
0032557272
-
Measles, Mumps, and Rubella - Vaccine Use and strategies for elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of The Advisory Committee on Immunization Practices (ACIP)
-
Center for Disease Control and Prevention
-
Center for Disease Control and Prevention (1998). "Measles, Mumps, and Rubella - Vaccine Use and strategies for elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: recommendations of The Advisory Committee on Immunization Practices (ACIP) ". MMWR Recomm Rep, 47:1-57.
-
(1998)
MMWR Recomm Rep
, vol.47
, pp. 1-57
-
-
-
8
-
-
0033582884
-
Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children-recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention (1999a). Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 48: 1-20.
-
(1999)
MMWR Recomm Rep
, vol.48
, pp. 1-20
-
-
-
9
-
-
0033575158
-
Intussusception among recipients of rotavirus vaccine, United States, 1998-1999
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention (1999b). Intussusception among recipients of rotavirus vaccine, United States, 1998-1999. MMWR Morb Mortal Wkly Rep; 48: 577-581.
-
(1999)
MMWR Morb Mortal Wkly Rep
, vol.48
, pp. 577-581
-
-
-
10
-
-
34548519302
-
Withdrawal of rotavirus vaccine recommendation
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention (1999c). Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep; 48: 1007.
-
(1999)
MMWR Morb Mortal Wkly Rep
, vol.48
, pp. 1007
-
-
-
11
-
-
42249091217
-
Impugning the integrity of medical science: The adverse effects of industry influence
-
Apr 16
-
DeAngelis C. D. & P. B. Fontanarosa (2008). Impugning the integrity of medical science: the adverse effects of industry influence. JAMA. Apr 16;299(15):1833-1835.
-
(2008)
JAMA
, vol.299
, Issue.15
, pp. 1833-1835
-
-
Deangelis, C.D.1
Fontanarosa, P.B.2
-
12
-
-
0037374498
-
The price of innovation: New estimates of drug development costs
-
March
-
DiMasi J. A.; Hansen R. W. & Grabowski H. G. (2003). The price of innovation: new estimates of drug development costs. Journal of Health Economics, Volume 22, Number 2, March, pp. 151-185(35).
-
(2003)
Journal of Health Economics
, vol.22
, Issue.2
, pp. 151-185
-
-
Dimasi J., A.1
Hansen, R.W.2
Grabowski, H.G.3
-
13
-
-
44949130775
-
Fallout from flip-flops
-
Froese P. (2008). Fallout from flip-flops. Nat Biotechnol Jun; 26(6):614-5.
-
(2008)
Nat Biotechnol Jun
, vol.26
, Issue.6
, pp. 614-615
-
-
Froese, P.1
-
14
-
-
4444342056
-
Rebuilding Big Pharma's Business Model
-
In Vivo, the Business & Medicine Report
-
Gilbert J, P. Henske & A. Singh (2003). "Rebuilding Big Pharma's Business Model," In Vivo, the Business & Medicine Report, Windhover Information, Vol. 21, No. 10.
-
(2003)
Windhover Information
, vol.21
, Issue.10
-
-
Gilbert, J.1
Henske, P.2
Singh, A.3
-
15
-
-
2342486044
-
The future of rotavirus vaccines: A major setback leads to new opportunities
-
Glass R. I. et al. (2004). The future of rotavirus vaccines: a major setback leads to new opportunities. The Lancet; 363:1547-1550.
-
(2004)
The Lancet
, vol.363
, pp. 1547-1550
-
-
Glass, R.I.1
-
16
-
-
79959370577
-
A Warning Shot: Influenza and the 2004 Flu Vaccine Shortage
-
Glezen P. (2006). A Warning Shot: Influenza and the 2004 Flu Vaccine Shortage. JAMA; 295: 1316-1317.
-
(2006)
JAMA
, vol.295
, pp. 1316-1317
-
-
Glezen, P.1
-
17
-
-
0034870303
-
The Precautionary Principle Also Applies to Public Health Actions
-
Goldstein B (2001). The Precautionary Principle Also Applies to Public Health Actions, American Journal of Public Health Vol 91, No. 9, 1358-1361.
-
(2001)
American Journal of Public Health
, vol.91
, Issue.9
, pp. 1358-1361
-
-
Goldstein, B.1
-
19
-
-
0031586446
-
Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis
-
Joensuu J. et al. (1997). Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet, 350: 1205-1209.
-
(1997)
Lancet
, vol.350
, pp. 1205-1209
-
-
Joensuu, J.1
-
20
-
-
34547148986
-
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer
-
Kerr D. J. et al. (2007). Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med, 357 (4): 360-369.
-
(2007)
N Engl J Med
, vol.357
, Issue.4
, pp. 360-369
-
-
Kerr, D.J.1
-
23
-
-
0035067033
-
Population-based study of rotavirus vaccination and intussusception
-
Kramarz P., E. K. France & Destefano, F. (2001). Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J; 20: 410-416.
-
(2001)
Pediatr Infect Dis J
, vol.20
, pp. 410-416
-
-
Kramarz, P.1
France, E.K.2
Destefano, F.3
-
24
-
-
0034877416
-
Reenergizing public health through precaution
-
Kriebel D. & J. Tickner. (2001). Reenergizing public health through precaution. Am J Public Health. 91 (9): 1351-1355.
-
(2001)
Am J Public Health
, vol.91
, Issue.9
, pp. 1351-1355
-
-
Kriebel, D.1
Tickner, J.2
-
25
-
-
0036570099
-
Timing of new black box warnings and withdrawals for prescription medications
-
Lasser K. E. et al. (2002). Timing of new black box warnings and withdrawals for prescription medications. JAMA. 287:2215-2220.
-
(2002)
JAMA
, vol.287
, pp. 2215-2220
-
-
Lasser, K.E.1
-
26
-
-
13844275317
-
Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children
-
Longini I. M. & M. E. Halloran (2005). Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children. American Journal of Epidemiology 161 (4):303-306.
-
(2005)
American Journal of Epidemiology
, vol.161
, Issue.4
, pp. 303-306
-
-
Longini, I.M.1
Halloran, M.E.2
-
27
-
-
34548340711
-
The precautionary principle: In action for public health
-
Martuzzi M. (2007). The precautionary principle: in action for public health, Occup Environ Med., 64: 569-570.
-
(2007)
Occup Environ Med
, vol.64
, pp. 569-570
-
-
Martuzzi, M.1
-
28
-
-
33845338724
-
Projection of global mortality and burden of disease from 2002 to 2030
-
Mathers C. D. & D. Loncar (2006). Projection of global mortality and burden of disease from 2002 to 2030. PLoS Medicine vol 3, 11, 2011-2030.
-
(2006)
PLoS Medicine
, vol.3
, Issue.11
, pp. 2011-2030
-
-
Mathers, C.D.1
Loncar, D.2
-
29
-
-
0034702441
-
Lifesaving vaccine caught in an ethical minefield
-
Melton L. (2000). Lifesaving vaccine caught in an ethical minefield. The Lancet, 356: 318-319.
-
(2000)
The Lancet
, vol.356
, pp. 318-319
-
-
Melton, L.1
-
30
-
-
0033973780
-
Policy analysis of the use of hepatitis B and rotavirus vaccines in national immunization schedules
-
Miller M. A. & L. Mc Cann (2000). Policy analysis of the use of hepatitis B and rotavirus vaccines in national immunization schedules. Health Econ, 9, 19-35.
-
(2000)
Health Econ
, vol.9
, pp. 19-35
-
-
Miller, M.A.1
McCann, L.2
-
31
-
-
0035931959
-
Intussusception among infants given an oral rotavirus vaccine
-
Murphy T. V., P. M. Gargiullo & M. S. Massoudi (2001). Intussusception among infants given an oral rotavirus vaccine. N Engl J Med; 344: 564-572.
-
(2001)
N Engl J Med
, vol.344
, pp. 564-572
-
-
Murphy T., V.1
Gargiullo, P.M.2
Massoudi, M.S.3
-
32
-
-
0037446785
-
Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions
-
Murphy B. R. et al. (2003). Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis; 187: 1301-1308.
-
(2003)
J Infect Dis
, vol.187
, pp. 1301-1308
-
-
Murphy, B.R.1
-
33
-
-
42249100174
-
Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: A case study based on documents from rofecoxib litigation
-
Psaty B. M. & R. A. Kronmal (2008). Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA;299(15):1813-1817.
-
(2008)
JAMA
, vol.299
, Issue.15
, pp. 1813-1817
-
-
Psaty, B.M.1
Kronmal, R.A.2
-
34
-
-
42249098105
-
Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation
-
Ross JS. et al. (2008). Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation. JAMA vol. 299, no 15, 1800-1812.
-
(2008)
JAMA
, vol.299
, Issue.15
, pp. 1800-1812
-
-
Ross, J.S.1
-
35
-
-
0030027092
-
Evidence-Based medicine: What it is and what it isn't
-
Sackett D. L. et al. (1996). Evidence-Based medicine: what it is and what it isn't, BMJ; 312:71-72.
-
(1996)
BMJ
, vol.312
, pp. 71-72
-
-
Sackett, D.L.1
-
36
-
-
0035856244
-
Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception
-
Simonsen L. et al. (2001). Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. The Lancet, vol 358, 1224-1229.
-
(2001)
The Lancet
, vol.358
, pp. 1224-1229
-
-
Simonsen, L.1
-
37
-
-
33646183685
-
How the US drug safety system should be changed
-
Strom B. (2006). How the US drug safety system should be changed, JAMA 295:2072-2075.
-
(2006)
JAMA
, vol.295
, pp. 2072-2075
-
-
Strom, B.1
-
38
-
-
0037425564
-
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
-
Thompson W. W et al. (2003). Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States: JAMA.: 289:179-186.
-
(2003)
JAMA
, vol.289
, pp. 179-186
-
-
Thompson, W.W.1
-
39
-
-
0032490140
-
Cost-effectiveness analysis of a rotavirus immunization program for the United States
-
Tucker A. W. et al. (1998). Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA, 279: 1371-1376.
-
(1998)
JAMA
, vol.279
, pp. 1371-1376
-
-
Tucker, A.W.1
-
40
-
-
30044442208
-
Safety and efficacy of a pentavalent Human - Bovine (WC3) reassortant rotavirus vaccine
-
Vesikari T., D. O. Matson & P. Dennehy (2006). Safety and efficacy of a pentavalent Human - Bovine (WC3) reassortant rotavirus vaccine. N Engl J Med; 354 (1): 75-77.
-
(2006)
N Engl J Med
, vol.354
, Issue.1
, pp. 75-77
-
-
Vesikari, T.1
Matson, D.O.2
Dennehy, P.3
-
41
-
-
37549024247
-
Regulator under siege
-
Dec 20
-
Wadman M. (2007). Regulator under siege. Nature. Dec 20;450(7173):1143
-
(2007)
Nature
, vol.450
, Issue.7173
, pp. 1143
-
-
Wadman, M.1
-
42
-
-
0038445612
-
Applying an equity lens to child health and mortality: More of the same is not enough
-
Victora C. G. et al. (2003). Applying an equity lens to child health and mortality: more of the same is not enough. The Lancet: vol 362: 233-241.
-
(2003)
The Lancet
, vol.362
, pp. 233-241
-
-
Victora, C.G.1
-
43
-
-
0034596547
-
The future of research into rotavirus vaccine. Benefits of vaccines may outweigh risk for children in developing country
-
Wejner C. (2000). The future of research into rotavirus vaccine. Benefits of vaccines may outweigh risk for children in developing country. BMJ, 321, 525-526.
-
(2000)
BMJ
, vol.321
, pp. 525-526
-
-
Wejner, C.1
-
45
-
-
10944252009
-
Ethics Versus Evidence In Influenza Vaccination
-
Zambon M. (2004). Ethics versus evidence in influenza vaccination. The Lancet, Vol 364, 9452: 2161-2163.
-
(2004)
The Lancet
, vol.364
, Issue.9452
, pp. 2161-2163
-
-
Zambon, M.1
-
46
-
-
79959347576
-
-
WEB SITES About EMEA structure, Accessed 1st July 2008, Permanent link
-
WEB SITES About EMEA structure: http://www.emea.europa.eu/htms/aboutus/emeaoverview.htm. Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz8KZstJ
-
-
-
-
47
-
-
79959342840
-
-
Sequence of Events with VIOXX, since opening of IND, Accessed 1st July 2008, Permanent link
-
Sequence of Events with VIOXX, since opening of IND: http://www.fda.gov/OHRMS/DOCKETS/AC/05/briefing/2005-4090B1_04_EFDA-TAB-C.htm Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz8VV9LG
-
-
-
-
48
-
-
79959362285
-
-
Jesse L. Goodman, M. D., M. P. H. Director, Center for Biologics, Evaluation and Research, May 4, 2005, Before the Committee on Energy and Commerce United States House of Representatives, Accessed 1st July 2008, Permanent link
-
Statement on influenza vaccine supply needs, Jesse L. Goodman, M. D., M. P. H. Director, Center for Biologics, Evaluation and Research, May 4, 2005, Before the Committee on Energy and Commerce United States House of Representatives. http://www.fda.gov/bbs/topics/news/2005/NEW01160.html, and: Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz7nqXMICDC
-
Statement On Influenza Vaccine Supply Needs
-
-
-
49
-
-
79959358630
-
-
Testimony February 10, 2005 on US Influenza Supply and Preparations for the Future before The Committee on Government Reform United States House of Representatives, Accessed 1st July 2008. Permanent link
-
Testimony February 10, 2005 on US Influenza Supply and Preparations for the Future before The Committee on Government Reform United States House of Representatives. http://www.hhs.gov/asl/testify/t050210b.html, Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz4uC1QxWHO
-
-
-
-
50
-
-
79959370099
-
-
World Health Report 2007, Permanent link, Accessed 1st July 2008
-
World Health Report 2007: http://www.who.int/whr/2007/chapter1/en/index.html, and: Permanent link http://www.webcitation.org/5Yz4NP83K Accessed 1st July 2008.
-
-
-
-
52
-
-
79959372061
-
-
US Department of Health and Human Services, Accessed 1st July 2008
-
US Department of Health and Human Services: http://www.hhs.gov/news/press/2006pres/20060504.html Accessed 1st July 2008. http://www.webcitation.org/5Yz3dSerh
-
-
-
-
53
-
-
79959340235
-
-
Sanofi-Aventis press releases, Accessed 1st July 2008, Permanent link
-
Sanofi-Aventis press releases: http://en.sanofi-aventis.com/press/ppc_18636.asp Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz3ar23n
-
-
-
|